Janis Naeve

Directeur/Membre du Conseil chez Ren Pharmaceuticals, Inc.

Profil

Janis C.
Naeve currently works at Ren Pharmaceuticals, Inc., as Director, Probius DX, Inc., as Director from 2022, and California Institute of Technology, as Member.
Dr. Naeve also formerly worked at Aurora Biosciences Corp., as Director-Business Development, DecImmune Therapeutics, Inc., as Director, Groove Biopharma Corp., as Director, Oncofactor Corp., as Director, NexImmune, Inc., as Director, X-Ceptor Therapeutics, Inc., as Director-Corporate Development, Amgen Ventures LLC, as Managing Director, Accelerator Services Corp, as Director, Acylin Therapeutics, Inc., as Director, Surface Oncology, Inc., as Director, Cota Capital Management LLC, as Venture Partner from 2022 to 2025, Alector, Inc., as Observer, and Incubate Coalition, as Advisory Council Member from 2020 to 2022.
Dr. Naeve received her doctorate degree from the University of Southern California and undergraduate degree from College of Business Administration (California).

Postes actifs de Janis Naeve

Sociétés	Poste	Début
Ren Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-
California Institute of Technology	Corporate Officer/Principal	-
Probius DX, Inc.	Directeur/Membre du Conseil	19/10/2022

Anciens postes connus de Janis Naeve

Sociétés	Poste	Fin
Cota Capital Management LLC	Private Equity Investor	01/06/2025
Incubate Coalition	Consultant / Advisor	01/04/2022
ALECTOR, INC.	Corporate Officer/Principal	-
Amgen Ventures LLC	Private Equity Investor	-
DecImmune Therapeutics, Inc.	Directeur/Membre du Conseil	-